Welcome to our dedicated page for Exelon SEC filings (Ticker: EXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Exelon Corporation (EXC) files a range of documents with the U.S. Securities and Exchange Commission that shed light on its operations as a Fortune 200 utility and parent of six fully regulated transmission and distribution companies. On this SEC filings page, you can review Exelon’s Forms 8-K, along with references to its annual reports on Form 10-K and quarterly reports on Form 10-Q, to better understand the company’s regulatory and financial disclosures.
Recent Form 8-K filings illustrate how Exelon uses current reports to communicate material events. These include combined filings for Exelon and its utilities—Commonwealth Edison (ComEd), PECO, BGE, Pepco Holdings, Potomac Electric Power Company, Delmarva Power & Light and Atlantic City Electric—when announcing quarterly results and related earnings presentations. Other 8-Ks describe matters such as a preliminary court approval of a proposed settlement of a consolidated stockholder derivative action, a temporary blackout period for the Employee Savings Plan tied to a vendor change, and changes in executive responsibilities for compliance, audit and risk.
Filings also reference Exelon’s capital markets activity. The company has reported an offering and pricing of convertible senior notes due 2029 in a private placement, outlining the terms of these senior unsecured obligations and stating that net proceeds are intended for debt repayment, refinancing or general corporate purposes. Such disclosures help investors track Exelon’s financing strategy and capital structure.
Through Stock Titan, users can access Exelon’s real-time SEC submissions as they are posted to EDGAR, including 10-K and 10-Q reports, 8-K current reports and exhibits. AI-powered summaries highlight key points from lengthy filings, such as risk factor discussions, legal proceedings, governance changes and financing terms, allowing readers to quickly identify items relevant to EXC’s regulated utility operations and corporate governance.
Exelon Corp director Bryan K. Segedi received an award of 878 common stock deferred stock units at $49.82 per unit under the Exelon Corp. Directors Deferred Stock Unit Plan. Following this grant, he holds 9,451 deferred stock units indirectly, including 72 units acquired through automatic dividend reinvestment.
Rogers Matthew C reported acquisition or exercise transactions in this Form 4 filing.
EXELON CORP director Matthew C. Rogers reported compensation-related equity awards. He received 739 deferred phantom share equivalents tied to Exelon common stock at $49.02 per equivalent, bringing his balance in this derivative instrument to 739 units, with 98 of these obtained through automatic dividend reinvestment.
He was also granted 878 shares of common stock in the form of deferred stock units at $49.82 per unit, held indirectly through the Exelon Corp. Directors Deferred Stock Unit Plan, increasing that plan balance to 12,554 units. The phantom share equivalents are part of a non-qualified deferred compensation plan and will be settled in cash on a 1-for-1 basis after his service on the board ends.
Exelon Corp director Anna Richo reported a grant of 878 common stock deferred stock units valued at $49.82 per unit. These units were credited under the Exelon Corp. Directors Deferred Stock Unit Plan and are held as an indirect interest, bringing her deferred stock unit balance to 11,337 units, including 87 acquired through automatic dividend reinvestment.
Separately, she holds 7,930 deferred phantom share equivalents in an Exelon stock fund within a multi-fund, non-qualified deferred compensation plan. According to the disclosure, these phantom share equivalents, which include 66 accrued through automatic dividend reinvestment, will be settled for cash on a 1-for-1 basis with Exelon common stock when her service on the board ends.
Lillie Charisse R reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Charisse R. Lillie reported routine equity-based compensation awards. She received 5 deferred phantom share equivalents tied to Exelon common stock at $49.02 per equivalent, bringing her phantom share balance to 3,855 equivalents. She was also credited with 878 common stock deferred stock units at $49.82 per unit through the Exelon Corp Directors Deferred Stock Unit Plan, increasing that plan balance to 12,554 units. Separately, she holds 7,246 shares of common stock directly, with both the share and phantom equivalent balances including amounts added through automatic dividend reinvestment. The phantom share equivalents are part of a non-qualified deferred compensation plan and will be settled for cash on a one-for-one basis when her board service ends.
Exelon Corp director Linda P. Jojo received a grant of 878 common stock deferred stock units on March 31, 2026, credited under the Exelon Corp Directors Deferred Stock Unit Plan. The units were valued at $49.82 per share. After this award, her indirect holdings total 56,036 deferred stock units, including 461 additional units acquired through automatic dividend reinvestment.
Exelon Corp director David G. DeWalt received a grant of 878 deferred stock units of common stock credited under the Exelon Corp. Directors Deferred Stock Unit Plan on March 31, 2026. These are indirect holdings used for director compensation rather than a market purchase or sale.
After this award, his indirect balance under the plan totaled 4,009 deferred stock units, which includes 26 additional units acquired through automatic dividend reinvestment.
Cheshire Marjorie Rodgers reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Marjorie Rodgers received additional deferred equity-based awards on March 31, 2026. She was granted 421 deferred phantom share equivalents tied to Exelon common stock at a reference price of $49.02, bringing her balance in this account to 10,013 phantom share equivalents.
She also received 878 deferred stock units of Exelon common stock at a reference price of $49.82 through the Exelon Corp. Directors Deferred Stock Unit Plan, increasing that indirect holding to 25,723 units. Footnotes note additional shares and phantom share equivalents have accumulated over time through automatic dividend reinvestment, and phantom share equivalents will be settled for cash on a 1-for-1 basis after her board service ends.
BOWERS WILLIAM P reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director William P. Bowers reported equity-based compensation awards rather than open-market trades. He received 880 deferred phantom share equivalents tied to Exelon common stock at a reference price of $49.02 each, bringing his phantom share balance to 20,158 equivalents.
He was also credited with 878 common stock deferred stock units at a reference price of $49.82 through the Exelon Corp Directors Deferred Stock Unit Plan, increasing that indirect holding to 19,978 units. A separate line shows a direct holding of 4,500 common shares. Footnotes note additional shares and phantom equivalents accrued through automatic dividend reinvestment and that phantom share equivalents are settled for cash after his board service ends.
The Vanguard Group filed Amendment No. 14 to Schedule 13G/A reporting 0 shares of Exelon Corp common stock, equal to 0% ownership. The filing states that on January 12, 2026 The Vanguard Group, Inc. underwent an internal realignment, and certain subsidiaries or business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538.
The amendment lists no sole or shared voting or dispositive power over Exelon common stock and notes that no other person holds more than 5% of the class in relation to the shares reported here.